SCHEMBL13423247

SCHEMBL13423247

O=C(c1ccc2c(c1)C1(c3ccccc3-c3ccccc31)c1c-2c2c(c3c1-c1ccc(C(=O)c4ccccc4F)cc1C31c3ccccc3-c3ccccc31)-c1ccc(C(=O)c3ccccc3F)cc1C21c2ccccc2-c2ccccc21)c1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 14/20 0.43
▸ MAPK14 Q16539 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ GMNN O75496 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TTR P02766 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12856595 0.91 PDK2 (0.48) PDK2MAPK14KDM4EMEN1GMNN
SCHEMBL13423240 0.85 PDK2 (0.50) PDK2TDP1
SCHEMBL13423248 0.85 PDK2 (0.43) PDK2MAPK14MEN1MAPTTHRB
SCHEMBL13423255 0.85 PDK2 (0.43) PDK2MAPK14MEN1MAPTTHRB
SCHEMBL13423253 0.84 BCL2 (0.44) PDK2MEN1MAPTKMT2ATDP1
SCHEMBL13423252 0.82 PDK2 (0.58) PDK2MEN1ALDH1A1CYP2C9RAB9A
SCHEMBL13423232 0.82 PDK2 (0.58) PDK2MEN1ALDH1A1CYP2C9RAB9A
SCHEMBL13423239 0.82 PDK2 (0.48) PDK2TDP1
SCHEMBL13423257 0.82 PDK2 (0.58) PDK2MEN1ALDH1A1CYP2C9RAB9A
SCHEMBL13423246 0.81 PDK2 (0.57) PDK2MEN1ALDH1A1CYP2C9RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683229-B2 truxene and isotruxene derivatives, in particular spirotruxene and spiroisotruxene derivatives; use thereof in organic electronic devices, in particular organic electroluminescent devices MERCK PATENT GMBH (DE) 2010-03-23 — — US disclosed
US-20080093980-A1 Organic Electroluminescent Device MERCK PATENT GMBH (DE) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080093980-A1 Organic Electroluminescent Device OXER1, NR3C2, OXTR PDK2 921/4885MAPK14 2070/4885KDM4E 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback